Comprehensive single-cell transcriptomic and proteomic analysis reveals NK cell exhaustion and unique tumor cell evolutionary trajectory in non-keratinizing nasopharyngeal carcinoma
Proteomics
Epstein-Barr Virus Infections
Herpesvirus 4, Human
Nasopharyngeal Carcinoma
Squamous Cell Carcinoma of Head and Neck
Research
R
Nasopharyngeal Neoplasms
single-cell RNA sequencing
3. Good health
NK cell exhaustion
Killer Cells, Natural
EBV
Head and Neck Neoplasms
Evolutionary trajectory
Medicine
Humans
Transcriptome
NK-NPC
DOI:
10.1186/s12967-023-04112-8
Publication Date:
2023-04-25T11:11:26Z
AUTHORS (7)
ABSTRACT
Abstract Background Nonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells and the tumor cell evolutionary trajectory in NK-NPC remain unclear. In this study, we aim to investigate function by single-cell transcriptomic analysis, proteomics immunohistochemistry. Methods (n = 3) normal mucosa cases were collected for proteomic analysis. Single-cell data 10) lymphatic hyperplasia (NLH, n obtained from Gene Expression Omnibus (GSE162025 GSE150825). Quality control, dimension reduction clustering based on Seurat software (v4.0.2) process batch effects removed harmony (v0.1.1) software. Normal identified using copykat (v1.0.8). Cell-cell interactions explored CellChat (v1.4.0). Tumor analysis was performed SCORPIUS Protein gene enrichment analyses clusterProfiler (v4.2.2). Results A total 161 differentially expressed proteins between (log 2 fold change > 0.5 P value < 0.05). Most associated nature killer mediated cytotoxicity pathway downregulated group. single transcriptomics, three subsets (NK1-3), among which exhaustion NK3 subset high ZNF683 expression (a signature tissue-resident cell) NK-NPC. We demonstrated presence + but not NLH. also immunohistochemical experiments TIGIT LAG3 confirm Moreover, revealed that status EBV infection (active or latent). cell-cell uncovered complex network cellular Conclusions This study might be induced upregulation inhibitory receptors surface Treatments reversal may promising strategy Meanwhile, unique active EBV-infection first time. Our provide new immunotherapeutic targets sight involving genesis, development metastasis
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (22)
CITATIONS (18)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....